Marco A. Ruiz Andia, MD, MPH, FACP, FIDSA
Advertisement

Marco A. Ruiz Andia, M.D., MPH, FACP, FIDSA, is chief of HIV Oncology and HIV Stem Cell Transplantation at Miami Cancer Institute as well as an attending physician in the BMT unit. Dr. Ruiz is a medical oncologist specializing in the treatment of hematologic cancers, including leukemia, lymphoma, myelodysplastic syndrome and myelofibrosis, as well as cancer combined with human immunodeficiency virus (HIV). He is an associate professor at Florida International University’s Herbert Wertheim College of Medicine.
Articles by Marco A. Ruiz Andia, MD, MPH, FACP, FIDSA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma
2
De-Escalated Neoadjuvant HER2-Targeted Therapy Shows Durable 5-Year Survival
3
Safusidenib Shows Durable Responses in IDH1-Mutant Glioma at 3-Year Follow-Up
4
Thoracic Radiotherapy Added to Atezolizumab Raised Toxicity in SCLC
5
